Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
594.5 DKK | -0.59% | +0.25% | +28.61% |
Apr. 16 | GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments | MT |
Apr. 04 | NKT to Invest EUR100 Million to Boost Medium-voltage Power Cable Production | MT |
Sales 2024 * | 21.92B 3.12B | Sales 2025 * | 23.13B 3.3B | Capitalization | 32.07B 4.57B |
---|---|---|---|---|---|
Net income 2024 * | 1.26B 180M | Net income 2025 * | 1.36B 194M | EV / Sales 2024 * | 1.24 x |
Net cash position 2024 * | 4.82B 687M | Net cash position 2025 * | 3.75B 534M | EV / Sales 2025 * | 1.22 x |
P/E ratio 2024 * |
25.5
x | P/E ratio 2025 * |
23.6
x | Employees | 4,449 |
Yield 2024 * |
-
| Yield 2025 * |
0.59% | Free-Float | 99.68% |
Latest transcript on NKT A/S
1 day | +1.36% | ||
1 week | +1.87% | ||
Current month | +4.91% | ||
1 month | +5.19% | ||
3 months | +25.42% | ||
6 months | +73.33% | ||
Current year | +28.93% |
Managers | Title | Age | Since |
---|---|---|---|
Claes Westerlind
CEO | Chief Executive Officer | 42 | 16-12-31 |
Michael Hjorth
CEO | Chief Executive Officer | 58 | 04-12-31 |
Line Fandrup
DFI | Director of Finance/CFO | 44 | 20-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jens Due Olsen
CHM | Chairman | 60 | 05-12-31 |
Director/Board Member | 69 | 15-12-31 | |
Andreas Nauen
BRD | Director/Board Member | 59 | 16-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 773 M€ | -.--% | - | |
0.02% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 596.5 | -0.25% | 90 507 |
24-04-18 | 598 | +1.36% | 80,615 |
24-04-17 | 590 | -0.17% | 75,639 |
24-04-16 | 591 | -1.83% | 152,564 |
24-04-15 | 602 | +1.18% | 121,919 |
Delayed Quote Nasdaq Copenhagen, April 18, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.93% | 4.58B | |
+3.30% | 147B | |
+18.47% | 128B | |
+28.29% | 124B | |
+12.31% | 62.49B | |
+7.51% | 40.99B | |
-11.91% | 31.34B | |
+68.67% | 30.94B | |
+4.58% | 30.78B | |
+2.47% | 26.88B |
- Stock Market
- Equities
- NKT Stock